AstraZeneca’s $1.1 Billion Acquisition of Icosavax

Centerview Partners LLC is serving as exclusive financial advisor to Icosavax and Goodwin is serving as legal counsel. Icosavax, Inc. (Nasdaq: ICVX) announced it has entered…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here